RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CARAVITA T
Collezione AOU Novara

Items : 3

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2018 Jul;144(7):1357-1366. doi: 10.1007/s00432-018-2641-5. Epub 2018 Apr 19

2018
AOU Città della Salute di Torino
AOU Novara

Gay F; Petrucci MT; Boccadoro M; Offidani M; Palumbo A; Corradini P; Musto P; Tacchetti P; Nagler A; Benevolo G; Ria R; Caravita T; Cangialosi C; Marcatti M; Ponticelli E; Baldini L; Rocco S; Cascavilla N; Rizzi R; Angelucci E; Nozzoli C; Oddolo D; Ben-Yehuda D; Guglielmelli T; Mina R; Crippa C; Patriarca F; Spada S; De Paoli L; et alii...

A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma. in Leukemia / Leukemia. 2016 Jun;30(6):1320-6. doi: 10.1038/leu.2016.36. Epub 2016 Feb 22.

2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Palumbo A; Sonneveld P; Offidani M; Boccadoro M; Musolino C; De Paoli L; Conticello C; Nozzoli C; Aghemo E; Derudas D; Genuardi M; Guglielmelli T; Carella AM; Ponticelli E; Spada S; Vincelli ID; De Rosa L; Omedé P; Morabito F; Montefusco V; Passera R; Benevolo G; Liberati AM; Falcone AP; Caravita T; Villani O; Oliva S; Petrucci MT; Bringhen S; et alii...

Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study. in Blood / Blood. 2014 Jul 3;124(1):63-9. doi: 10.1182/blood-2014-03-563759. Epub 2014 May 22.

2014
AOU Città della Salute di Torino
AOU Novara

Boccadoro M; Caravita T; Tacchetti P; Oliva S; Montefusco V; Genuardi M; Benevolo G; Ciccone G; Gentilini F; Offidani M; Omedé P; Boccadifuoco L; Musto P; Magarotto V; Rossi D; Conticello C; Larocca A; Petrucci MT; Bringhen S; Sonneveld P; Palumbo A;